# A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)

> **NCT01613378** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 200 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT01613378
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2016-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01613378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01613378, "A Non-Interventional Study in Rheumatoid Arthritis Patients Treated With Tocilizumab (RoActemra/Actemra)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01613378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*